✦ LIBER ✦

Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

✍ Scribed by Ringman, John M; Frautschy, Sally A; Teng, Edmond; Begum, Aynun N; Bardens, Jenny; Beigi, Maryam; Gylys, Karen H; Badmaev, Vladimir; Heath, Dennis D; Apostolova, Liana G; Porter, Verna; Vanek, Zeba; Marshall, Gad A; Hellemann, Gerhard; Sugar, Catherine; Masterman, Donna L; Montine, Thomas J; Cummings, Jeffrey L; Cole, Greg M

Book ID: 120447189
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 320 KB
Volume: 4
Category: Article
ISSN: 1758-9193
DOI: 10.1186/alzrt146

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 24-week, randomized, double-blind, pla

A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease

✍ Nakamura, Yu; Imai, Yukimichi; Shigeta, Masahiro; Graf, Ana; Shirahase, Toru; Ki 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

P4-344: Oral curcumin for the treatment

P4-344: Oral curcumin for the treatment of mild-to-moderate Alzheimer's disease: Tolerability and clinical and biomarker efficacy results of a placebo-controlled 24-week study

✍ Ringman, John M.; Cole, Greg; Teng, Edmond; Badmaev, Vladimir; Bardens, Jenny; F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Efficacy and Tolerability of Oral Zolmit

Efficacy and Tolerability of Oral Zolmitriptan in Menstrually Associated Migraine: A Randomized, Prospective, Parallel-Group, Double-blind, Placebo-Controlled Study

✍ Elizabeth Loder; Stephen D. Silberstein; Susan Abu-Shakra; Loretta Mueller; Timo 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Efficacy and Tolerability of Almotriptan

Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial

✍ Steven L. Linder; Ninan T. Mathew; Roger K. Cady; Gary Finlayson; Gary Ishkanian 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

A 24-week, double-blind, placebo-control

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease—pilot study

✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This

Effects of Varenicline in Adult Smokers:

Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study

✍ Chris T. Bolliger; Jaqueline S. Issa; Rodolfo Posadas-Valay; Tarek Safwat; Paula 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 531 KB